Biodesix and HiberCell collaborate for companion diagnostic discovery, development and commercialization

Biodesix and HiberCell collaborate for companion diagnostic discovery, development and commercialization

BOULDER NEW YORK -- Biodesix, Inc. (Nasdaq: BDSX) today announced an agreement with HiberCell , a biotechnology company developing novel therapeutics for cancer relapse and metastasis, to further... Read More

Friday January 15, 2021 0 comments Tags: Boulder, Biodesix, HiberCell, Scott Hutton